Elizabeth Sanguinetti - Salt Lake City UT, Thomas Marriott - Sandy UT, Jennifer Lopansri - Salt Lake City UT, Consuelo Blosch - Mercer Island WA,
International Classification:
A61K 38/17
US Classification:
514012000
Abstract:
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Treatment Of Short Bowel Syndrome Patients With Colon-In-Continuity
Elizabeth Lemaire Sanguinetti - Salt Lake City UT, Thomas B. Marriott - Sandy UT, Jennifer Lopansri - Salt Lake City UT, Consuelo Maria Blosch - Mercer Island WA,
Assignee:
NPS Pharmaceuticals, Inc. - Bedminster NJ
International Classification:
A61K 38/26 A61P 1/00 A61P 1/02
US Classification:
514 117
Abstract:
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Resumes
Associate Clinical Project Management Director At Quintiles